Trademark: ENABLEMENT
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for ENABLEMENT
We do not have any records of a proof of use for ENABLEMENT at this moment.
Possible trademark infringements of ENABLEMENT
Basic Information about ENABLEMENT
- Serial Number
- 86779885
- Filing Date
- 06 Oct 2015
- Registration Number
- 5080504
- Registration Date
- 15 Nov 2016
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of ENABLEMENT on the blockchain with WikiTrademarks.io.
- First use of ENABLEMENT anywhere
- ENABLEMENT was first used on 30 Nov 2012 for the primary classification of goods and services, international, 009 (Electrical and scientific apparatus)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 009
- US Codes
- 021; 023; 026; 036; 038
Who owns ENABLEMENT?
1. Advent Business Company Inc. Naperville IL
2. Advent Business Company Inc. Naperville IL
3. Advent Business Company Inc. Naperville IL
Correspondent
- Advent Business Company Inc.
- 3023 Rollingridge Rd
- Naperville IL 60564
Recent News about ENABLEMENT
Amgen v. Sanofi: Seven Months In, Has Anything About Patent Enablement Changed? Tweet this
Best Practices for Conquering the Enablement Requirement After Amgen Tweet this
SCOTUS Ushers in New Era of Enablement Law in Amgen Ruling Tweet this
Amgen Reply Brief Addresses Mischaracterizations by Sanofi, U.S. Government on Proper Enablement Inquiry for Genus Claims Tweet this
Amici Filings in Amgen Encourage the Supreme Court to Correct the Federal Circuit’s ‘Unworkable’ Enablement Standard Tweet this
SCOTUS Takes on Scope of Enablement Inquiry in Amgen v. Sanofi: Implications for Pharma/ Biotech and Beyond Tweet this
Other Barks & Bites for Friday, October 7: OSTP Publishes AI Bill of Rights Blueprint, Amgen Files Supplement Brief on Enablement Appeal, and Longtime Register of Copyrights Peters Passes Away Tweet this
Review Not Warranted: SG Tells SCOTUS to Scrap Amgen’s Case on Enablement Test for Biotech Patents Tweet this
CAFC Denies Amgen Petition to Reconsider Enablement Test for Biotech Patents Tweet this
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io